InvestorsHub Logo

NewJerichoMan

02/21/17 6:24 PM

#2057 RE: InvestforLTerm #2055

The point is there is no low hanging fruit out there.



Nos. 1, 2 and 3 reply. We bought Bucha for $900K. We bought Xing for $20M. On the backs of those two acquisitions, we went from pennies to the Nasdaq. It remains to be seen what Marley is going to cost us. But that's 3 acquisitions in less than a year.

Your opinion does not comport with reality.


Your $400 mn. and share price targets is just not a realistic scenario unfortunately.



It's an absolute perfect time in this sector to have an entire portfolio of only "better-for-you" products. $400M sounds like a big number when you're staring at a run-rate of $70M (probably $80M after Xing/House Brand/Circle K deal) and would impute a growth rate of 125% per annum (based on the $80M number). But if cross-selling takes hold throughout the entire distribution network (25K outlets nationally) then the math isn't that daunting.

joenatural

02/22/17 9:20 AM

#2063 RE: InvestforLTerm #2055

Sorry .... there are no flaws in my logic. Was the Xing acquisition massively dilutive ? Brent will convince others like Xing to sell on the cheap and be rewarded by future stock price. Both Xing and Marley owners told me that Brent is a rock star (exact words). You discount the massive distribution from combining successful products. You didn't even mention NBEV's current work with the NIH, which by itself may very well be worth more than all else combined. ECIG ? What on earth does that have to do with NBEV ? Oh that's right ..... nothing. When I say $20 to $30 for the stock price, that's a short term target. I say multi-bags higher from here within Brent's end of 2019 time frame and well above $50. Their internal price targets actually make mine look like child's play.

Run4Cover

02/22/17 10:22 AM

#2064 RE: InvestforLTerm #2055

InvestforLTerm - excellent summary. You are spot on regarding the CEO and the "irrational exuberance" demonstrated by a few. They don't want to hear the truth about the CEO (ask the Board of Directors at Cott, Kmart , ecig, hemorrhoid company , etc). Saying that he "exaggerates" is a severe understatement. The facts don't lie : he comes in with delusions of grandeur and good presentations, raises expectations of shareholders, does a few PR moves, makes an acquisition and then dilutes the hell out of everyone despite saying he won't. Yet, a few continue to drink the Koolaide and stick their heads in the sand because "he told me he was great ". Laughable and sad at the same time.
The stock is following the same trend as he did at ecig etc.
He bought a company (xing) that no one , no one wanted. He didn't "get it on the cheap". No one wanted it. It had been for sale for over a year
The bottom is going to fall??, as it always does . He's already blown his promise on "no dilution".
Keep watching ....